New company plans to develop exosomes capable of delivering miRNAs and proteins

December 26, 2013 Leave a comment

from GEN News Highlights Intrexon Buys Stem Cell Tech Developer Medistem for $26M Intrexon said today it will acquire Medistem for $26 million, in a deal that will integrate the acquired company’s endometrial regenerative cells (ERCs) and the acquirer’s integrated ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: UltraVector® platform

New company plans to develop exosomes capable of delivering miRNAs and proteins

Researchers develop a blood test to identify individuals at risk of developing Parkinson’s disease

Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines

Extracellular vesicles from the placenta may offer major clues on the in utero development of neurobehavioral disorders

Exai Bio’s RNA- and AI-based Liquid Biopsy Platform Detects Early Stage Breast Cancer with High Accuracy, Overcoming Many Limitations of DNA-based Approaches

HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment

NVIGEN unveils groundbreaking comprehensive liquid biopsy – multimodal biomarker detection enabled by highly versatile nanoparticle capture